These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3992688)

  • 21. [Treatment of malignancy-associated hypercalcemia].
    Endo I; Inoue D
    Clin Calcium; 2006 Apr; 16(4):665-69. PubMed ID: 16582519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease.
    Tucci M; Mosca A; Lamanna G; Porpiglia F; Terzolo M; Vana F; Cracco C; Russo L; Gorzegno G; Tampellini M; Torta M; Reimondo G; Poggio M; Scarpa RM; Angeli A; Dogliotti L; Berruti A
    Prostate Cancer Prostatic Dis; 2009; 12(1):94-9. PubMed ID: 18332901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypercalcemic bone metastases of malignant melanoma].
    Garcier F; Claudy AL; Tolot O; Chappard D; Riffat G
    Ann Dermatol Venereol; 1984; 111(6-7):589-92. PubMed ID: 6497255
    [No Abstract]   [Full Text] [Related]  

  • 24. [Biphosphonates in oncology].
    Khosravi Shahi P; Díaz Muñoz de la Espada V
    An Med Interna; 2005 Nov; 22(11):544-7. PubMed ID: 16454591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypercalcemia in malignant diseases without bone metastases].
    Schioler K; Hansen JM
    Ugeskr Laeger; 1966 Jan; 128(3):87-8. PubMed ID: 5916278
    [No Abstract]   [Full Text] [Related]  

  • 26. Experience with hypercalcemia and osteoporosis of neoplastic disease.
    Ambrus JL; Ambrus CM; Lillie DB
    J Med; 1984; 15(4):310-8. PubMed ID: 6396360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia].
    Delmas PD; Charhon SA; Chapuy MC; Meunier PJ
    Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):663-6. PubMed ID: 6523018
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
    Chapuy MC; Meunier PJ; Alexandre CM; Vignon EP
    J Clin Invest; 1980 May; 65(5):1243-7. PubMed ID: 6444955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Malignant hypercalcemia with and without bone metastasis].
    Millán Núñez-Cortés J; de Moneo González A
    Rev Clin Esp; 1996 Jun; 196(6):388-91. PubMed ID: 8767075
    [No Abstract]   [Full Text] [Related]  

  • 30. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
    Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Endocrinological examination of malignant tumors. Hypercalcemia in malignant tumors].
    Abe K
    Rinsho Byori; 1974 Oct; 22(10 Suppl):28. PubMed ID: 4475870
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hypercalcemia in malignancy].
    Eto S
    Rinsho Byori; 1994 Sep; 42(9):943-51. PubMed ID: 7967119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of parathyroid hormone messenger RNA in malignant disease with hypercalcemia.
    N Engl J Med; 1984 Feb; 310(5):323-4. PubMed ID: 6690960
    [No Abstract]   [Full Text] [Related]  

  • 34. Hypercalcemia of malignancy: a review of advances in pathophysiology.
    Kaplan M
    Oncol Nurs Forum; 1994 Jul; 21(6):1039-46; quiz 1047-8. PubMed ID: 7971410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypercalcemia and metastasis.
    Martin TJ
    Lancet; 1982 Nov; 2(8309):1216. PubMed ID: 6128516
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypercalcemia in neoplastic diseases.
    Frenning DH
    Minn Med; 1979 Jul; 62(7):541-3. PubMed ID: 492106
    [No Abstract]   [Full Text] [Related]  

  • 37. Mithramycin for hypercalcemia of malignant disease.
    Godfrey TE
    Calif Med; 1971 Oct; 115(4):1-4. PubMed ID: 4255688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer hypercalcemia: recent advances in understanding and treatment.
    Body JJ
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):865-9. PubMed ID: 6378642
    [No Abstract]   [Full Text] [Related]  

  • 39. Supportive care.
    Markman M
    Cancer Chemother Biol Response Modif; 1994; 15():665-74. PubMed ID: 7779606
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypercalcemia due to primary hyperparathyroidism or malignant disease. Evaluated by means of biochemical tests and the steroid suppression test.
    Kvetny J; Orthman-Brask H; Frederiksen PK; Jest P; Jensen E; Jacobsen JG
    Acta Med Scand; 1982; 212(3):163-6. PubMed ID: 7148507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.